What is Rett syndrome?
Rett syndrome (RTT) is a rare neurological disorder that primarily affects girls and women, causing severe impairments in language, movement, and cognitive function. The condition is characterized by a period of normal early development followed by regression of acquired skills, typically between 6 months and 4 years of age. Rett syndrome affects approximately 1 in 10,000 female births worldwide, making it one of the leading genetic causes of intellectual disability in girls. The disorder is caused by mutations in the MECP2 gene on the X chromosome and follows an X-linked dominant inheritance pattern.
Key statistics
| Prevalence | ~1 in 10,000 female births |
| Age of onset | Regression typically begins between 6 months – 4 years |
| Gender distribution | 95% female (males typically more severely affected) |
| Genetic cause | MECP2 mutations in ~95% of cases |
Symptoms
Primary symptoms: Hand-wringing stereotypies, developmental regression, microcephaly, gait apraxia, breathing irregularities, seizures, intellectual disability, loss of purposeful hand movements, communication difficulties.
The clinical presentation of Rett syndrome follows a characteristic pattern through four distinct stages. During Stage I (6-18 months), parents may notice developmental stagnation, reduced eye contact, and diminished interest in play. The hallmark regression occurs in Stage II (1-4 years), when previously acquired skills like speech and purposeful hand use are lost. Children develop the characteristic repetitive hand-wringing or hand-washing movements that become constant during waking hours.
Stage III (2-10 years) represents a period of relative stability, though severe intellectual disability persists. Many children develop seizures, breathing irregularities including breath-holding and hyperventilation, and sleep disturbances. Scoliosis often emerges during this stage. Stage IV (after 10 years) is marked by reduced mobility, muscle weakness, and progressive scoliosis, though seizures may decrease and eye contact often improves.
Additional symptoms include growth retardation leading to small stature, teeth grinding (bruxism), difficulty swallowing, constipation, and temperature regulation problems. Many individuals experience intense staring episodes and may show autistic-like behaviors, though social interest typically remains stronger than in classic autism.
Causes and risk factors
Rett syndrome is primarily caused by mutations in the MECP2 gene located on the X chromosome. This gene produces methyl-CpG-binding protein 2, which plays a crucial role in regulating the expression of other genes, particularly in brain development and function. Over 95% of individuals with classic Rett syndrome have identifiable MECP2 mutations.
The condition follows an X-linked dominant inheritance pattern, but approximately 99% of cases occur as de novo (spontaneous) mutations rather than being inherited from parents. Because females have two X chromosomes, they can survive with one mutated copy due to X-inactivation, where cells randomly inactivate one X chromosome. Males, having only one X chromosome, are typically more severely affected and often do not survive to birth or early infancy, explaining why Rett syndrome predominantly affects females.
Atypical forms of Rett syndrome may be caused by mutations in other genes, including CDKL5 and FOXG1. Advanced maternal age slightly increases the risk of de novo mutations, but most cases occur regardless of parental age or family history.
Prevention
As Rett syndrome is primarily caused by spontaneous genetic mutations, there are no established methods for prevention. However, genetic counseling and testing options are available for families. Carrier testing can identify women who carry MECP2 mutations, though this is rarely relevant since most cases are de novo mutations.
Prenatal testing through amniocentesis or chorionic villus sampling can detect MECP2 mutations if there is a known family history or if parents are carriers. Preimplantation genetic diagnosis (PGD) may be considered for families with a known mutation. Given the predominantly sporadic nature of the condition, routine screening is not recommended for the general population.
Complications
Without appropriate management, Rett syndrome can lead to numerous serious complications. Scoliosis affects up to 85% of individuals and can progress rapidly, potentially causing respiratory compromise if severe. Seizures occur in 60-80% of cases and can be difficult to control, sometimes leading to status epilepticus.
Breathing irregularities can result in chronic hypoxemia and may contribute to sudden death, which occurs in 1-2% of individuals annually. Gastrointestinal problems including severe constipation, gastroesophageal reflux, and swallowing difficulties can lead to malnutrition and aspiration pneumonia.
Cardiac complications may include prolonged QT interval, which increases the risk of dangerous arrhythmias. Osteoporosis and frequent fractures often develop due to limited mobility, nutritional deficiencies, and medication effects. Sleep disturbances are nearly universal and significantly impact both the individual and family quality of life.
Diagnosis
Diagnosis of Rett syndrome relies on clinical criteria established by the International Rett Syndrome Foundation, combined with genetic testing. The clinical diagnosis requires a period of regression followed by recovery or stabilization, along with specific supportive criteria including loss of purposeful hand skills, loss of spoken language, gait abnormalities, and characteristic hand stereotypies.
Genetic testing for MECP2 mutations confirms the diagnosis in approximately 95% of individuals meeting clinical criteria. Testing typically uses sequencing and deletion/duplication analysis. If MECP2 testing is negative in individuals with atypical presentations, testing for CDKL5 and FOXG1 mutations may be considered.
Additional diagnostic evaluations include electroencephalography (EEG) to assess for seizures, brain MRI to rule out other causes of regression, and metabolic testing if the clinical picture is unclear. Spinal X-rays monitor for scoliosis development, and cardiac evaluation including ECG assesses for QT prolongation.
Treatment
Treatment for Rett syndrome is primarily supportive and multidisciplinary. Trofinetide became the first FDA-approved medication specifically for Rett syndrome in 2023, showing benefits in improving communication and reducing symptoms in clinical trials.
Seizure management typically involves antiepileptic drugs such as carbamazepine, lamotrigine, or levetiracetam. Breathing irregularities may be managed with naltrexone in low doses. Gastrointestinal symptoms often require polyethylene glycol for constipation and proton pump inhibitors for reflux.
Physical therapy focuses on maintaining mobility and preventing contractures, while occupational therapy addresses daily living skills and communication aids. Speech therapy emphasizes alternative communication methods including eye-gaze devices and picture boards. Orthopedic interventions including spinal fusion may be necessary for severe scoliosis.
Nutritional support through gastrostomy tubes may be required for individuals with severe swallowing difficulties. Regular monitoring includes assessments of growth, scoliosis progression, cardiac function, and seizure control.
Prognosis
The prognosis for Rett syndrome varies significantly based on the type of mutation and severity of symptoms. Most individuals survive to adulthood, with life expectancy ranging from 40-60 years, though some may have shorter lifespans due to complications. The annual risk of sudden death is estimated at 1-2%, often related to cardiac arrhythmias or breathing irregularities.
Functional abilities typically plateau during the teenage years, though some individuals may show modest improvements in social engagement and communication. Seizures often improve with age, and many adults experience fewer breathing irregularities than during childhood.
Quality of life can be significantly impacted, but with appropriate support, many individuals maintain social connections and can participate in family and community activities. Early intervention and comprehensive care management improve outcomes and may help preserve some functional abilities.
Quality of life
Individuals with Rett syndrome require comprehensive daily support for most activities of living. Communication often relies on eye-gaze, facial expressions, and assistive technology devices. Many enjoy music therapy, which can improve mood and social engagement.
Nutritional needs require careful attention, with many individuals requiring modified textures or tube feeding. Regular physical therapy helps maintain joint flexibility and may slow the progression of scoliosis. Hydrotherapy is often well-tolerated and enjoyable.
Sleep routines benefit from consistent schedules and comfortable positioning. Environmental modifications including padding for hand stereotypies and seizure precautions enhance safety. Educational programs focus on sensory experiences and social interaction rather than traditional academic skills.
Family support is crucial, as caregiving demands are intensive. Respite care services and support groups provide essential relief and connection with other families facing similar challenges.
Pregnancy and fertility
Most individuals with Rett syndrome do not become pregnant due to the severity of their intellectual disability and need for full-time care. However, biological fertility is generally preserved, and rare cases of pregnancy have been reported in mildly affected individuals.
For families planning future pregnancies, genetic counseling is recommended. Since most cases are de novo mutations, the recurrence risk is generally low (less than 1%) unless a parent carries a germline mutation. Prenatal testing can be offered for known familial mutations.
Women who are carriers of MECP2 mutations may have mild symptoms and normal intelligence, and their pregnancy management would focus on genetic counseling and prenatal testing options.
Children
Rett syndrome is primarily a pediatric-onset condition, with regression typically beginning in early childhood. Early intervention services are crucial and should include physical, occupational, and speech therapy. Special education programs must accommodate the unique learning profile of children with Rett syndrome.
Pediatric management focuses on seizure control, nutritional support, and monitoring for complications like scoliosis. Growth charts specific to Rett syndrome help track development appropriately. Sleep disturbances are common and may require behavioral interventions or medications.
Social interaction remains a strength for many children, and inclusive activities that don’t require verbal communication can be beneficial. Music therapy and sensory activities are often well-received and may support developmental progress.
When to see a doctor
Urgent medical attention is needed for prolonged seizures lasting more than 5 minutes, severe breathing difficulties, signs of aspiration pneumonia (fever, cough, difficulty breathing), or cardiac symptoms including chest pain or fainting episodes.
Regular medical follow-up should occur every 3-6 months and include monitoring for scoliosis progression, seizure control, nutritional status, and cardiac function. Annual evaluations should include spinal X-rays, ECG, and comprehensive developmental assessment.
Parents should seek medical advice for new or worsening symptoms including increased seizure frequency, feeding difficulties, sleep disturbances, or behavioral changes that might indicate pain or illness.
Regional context
Limited specific data exists regarding Rett syndrome prevalence in the Caucasus region (Georgia, Armenia, Azerbaijan) or the broader Eastern Mediterranean. The condition likely occurs at similar rates to global estimates, but diagnostic capabilities and awareness may vary between countries.
Healthcare infrastructure differences may impact access to genetic testing, specialized therapies, and multidisciplinary care teams. The Global Medical Journal welcomes contributions from healthcare providers and researchers in these regions to better understand local prevalence, diagnostic challenges, and treatment accessibility for Rett syndrome and other rare neurological conditions.
Research and clinical trials
Current research focuses on several therapeutic approaches including gene therapy, protein replacement, and small molecule drugs targeting the underlying pathophysiology. Clinical trials are investigating potential treatments for core symptoms and specific complications.
Ongoing studies examine the effectiveness of trofinetide in longer-term use and different age groups. Gene therapy approaches aim to restore MECP2 function, with early-stage trials showing promise. Research into biomarkers may improve monitoring of disease progression and treatment response.
ClinicalTrials.gov lists numerous active studies investigating potential therapies. Families interested in clinical trial participation should discuss options with their healthcare team and consider contacting specialized Rett syndrome research centers.
Frequently asked questions
Will my child with Rett syndrome be able to communicate?
While verbal communication is typically severely limited, many individuals maintain strong social awareness and can communicate through eye gaze, facial expressions, and assistive technology devices. Communication abilities vary significantly between individuals.
Is Rett syndrome inherited from parents?
Approximately 99% of Rett syndrome cases result from spontaneous genetic mutations rather than inheritance. The recurrence risk for future pregnancies is generally less than 1% unless a parent carries a germline mutation.
Can males have Rett syndrome?
Males can be affected but much more rarely, as they typically have more severe symptoms due to having only one X chromosome. Male survivors often have milder mutations or chromosomal variations like Klinefelter syndrome (XXY).
Will seizures in Rett syndrome get better with age?
Many individuals experience improvement in seizure frequency and severity during adolescence and adulthood. However, seizure patterns vary significantly, and some individuals continue to require antiepileptic medications throughout life.
What is the life expectancy for someone with Rett syndrome?
Most individuals with Rett syndrome survive to adulthood, with life expectancy ranging from 40-60 years. The annual risk of sudden death is 1-2%, often related to cardiac or breathing complications.
Support and resources
- International Rett Syndrome Foundation – rettsyndrome.org
- Orphanet – orpha.net
- National Organization for Rare Disorders (NORD) – rarediseases.org
- EURORDIS – eurordis.org
- Rett Syndrome Europe – rettsyndrome.eu
- ClinicalTrials.gov – clinicaltrials.gov
Related conditions
- Angelman syndrome
- Autism spectrum disorder
- CDKL5 deficiency disorder
- Childhood disintegrative disorder
- Pitt-Hopkins syndrome
Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, relevant guidelines. Informational only; not medical advice. CC BY 4.0.
Cite this page
GMJ News Desk. “Rett syndrome.” GMJ News — Georgian Medical Journal, 2 June 2026. https://news.gmj.ge/condition/rett-syndrome/
Licensed under CC BY 4.0. Free to share with attribution to GMJ News.Sources: Orphanet (orpha.net), OMIM, GeneReviews (NCBI), WHO ICD-11, EULAR/ACR guidelines. Schema.org MedicalCondition structured data included.
Was this article helpful?